| Dr Charles Phillips Wilson, PD | |
|
10130 Honeysuckle Rd, Belleville, AR 72824-8940 | |
| (479) 495-0276 | |
| Not Available |
| Full Name | Dr Charles Phillips Wilson |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 10130 Honeysuckle Rd, Belleville, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598799249 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 6294 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Charles Phillips Wilson, PD 10130 Honeysuckle Rd, Belleville, AR 72824-8940 Ph: (479) 495-0276 | Dr Charles Phillips Wilson, PD 10130 Honeysuckle Rd, Belleville, AR 72824-8940 Ph: (479) 495-0276 |
News Archive
The University of Rhode Island, in collaboration with BayCare Health System in Florida and The Memory and Aging Program at Butler Hospital, an affiliate of The Warren Alpert Medical School of Brown University, is launching a clinical trial of retinal screening processes that could help clinicians detect Alzheimer's disease possibly two or more decades before patients develop life-altering clinical symptoms.
A recently identified immune cell that directs other cells to fight infection plays a critical role in regulating the immune system in both health and disease. Researchers from the University of Pennsylvania School of Medicine have discovered how a stimulatory molecule and a protein found on the membrane of another immune cell make T helper 17 cells multi-taskers of sorts. Th17 cells protect the body against infection and cancer, but are also culprits in some autoimmune diseases and out-of-control, cancerous cell growth.
Researchers at the Indian Institute of Technology, Guwahati, have made an important discovery about a viral fusion protein found on the surface of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that could help researchers develop a vaccine.
More than 10 percent of women with breast cancer stopped taking a commonly prescribed drug because of joint and muscle pain, according to a new study from researchers at the University of Michigan Comprehensive Cancer Center.
The American Society of Hematology (ASH) joined the European Hematology Association (EHA) and the European Cancer Patient Coalition (ECPC) today in issuing a common call to action in an effort to mitigate shortages of hematologic drugs in the United States and around the world.
› Verified 6 days ago